Russell Bradley has become vice president of business development and strategic planning of Luminex, the Austin, Texas-based company said on Monday. In addition, Gregory Gosch has become vice president of marketing and sales, and Randel Marfin vice president of the Luminex Bioscience Group, a new position.
Most recently, Bradley was director of Beckman Coulter's Cares initiative. He holds a bachelor of science degree in immunology and biochemistry from Monash University in Australia.
Roger Wiegand has become director of the infectious disease initiative at the Broad Institute. Prior to joining the Broad, he was chief scientific officer of Cantata Laboratories in Cambridge, Mass.
Reg Jones will retire as chief financial officer of Stratagene, effective June 30, the company said last week. Jones, who will remain a company consultant, will be replaced by Steve Martin, the company's director of finance. Prior to joining Stratagene a year ago, he was the controller of GenProbe.